1. Home
  2. ULH vs LYEL Comparison

ULH vs LYEL Comparison

Compare ULH & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

N/A

Current Price

$15.68

Market Cap

462.1M

Sector

Industrials

ML Signal

N/A

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

N/A

Current Price

$25.67

Market Cap

490.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULH
LYEL
Founded
1932
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.1M
490.1M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
ULH
LYEL
Price
$15.68
$25.67
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$17.00
$25.00
AVG Volume (30 Days)
34.5K
91.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.73%
N/A
EPS Growth
39.66
N/A
EPS
N/A
N/A
Revenue
$1,461,708,000.00
$61,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.78
$0.39
52 Week High
$30.76
$45.00

Technical Indicators

Market Signals
Indicator
ULH
LYEL
Relative Strength Index (RSI) 43.61 56.89
Support Level $14.82 $21.27
Resistance Level $19.31 $27.30
Average True Range (ATR) 1.34 2.01
MACD -0.07 0.19
Stochastic Oscillator 28.11 84.87

Price Performance

Historical Comparison
ULH
LYEL

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: